Results 21 to 30 of about 292,142 (337)
Alcohol use in opioid agonist treatment [PDF]
Addiction Science & Clinical Practice, 2016 Alcohol misuse among individuals receiving agonist treatment for an opioid use disorder is common and is associated with significant morbidity and mortality. At present, though substantial research highlights effective strategies for the screening, diagnosis and management of an alcohol or opioid use disorder individually, less is known about how best ...
Nolan, Seonaid, Klimas, Jan, Wood, Evan
openaire +4 more sources
Trends in use of medicines for opioid agonist treatment in Australia, 2013-2022.
The International journal on drug policy, 2023 BACKGROUND There are limited longitudinal data on national patterns of opioid agonist treatment (OAT). This study describes 10-year trends in the sales of OAT medicines in Australia.
C. Bharat +5 more
semanticscholar +1 more source
Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada.
The International journal on drug policy, 2023 BACKGROUND Injectable opioid agonist treatment (iOAT) has recently been expanded in some geographical contexts in Canada as part of a response to the escalating overdose crisis.
Samara Mayer +6 more
semanticscholar +1 more source
JAMA Network Open, 2023 Key Points Question How have rates of opioid agonist treatment (OAT) and opioid-related deaths in youths changed over the last 9 years and how does this compare to trends among adults?
Tea Rosic +4 more
semanticscholar +1 more source
International Journal of Population Data Science, 2022 Objectives There are critical periods of mortality risk at onset and cessation of opioid agonist treatment. We aim to determine whether non-fatal overdose followed the same pattern as fatal overdose, comparing the first 4 weeks of treatment and ...
Nicola Jones +6 more
doaj +1 more source
Nontraditional Alcohol and Opioid Agonist Treatment Interventions [PDF]
Medical Clinics of North America, 2018 Despite the availability of effective medications and psychosocial interventions for the management of a substance use disorder, some individuals repeatedly fail the most aggressive treatment regimens. For such individuals, alternative treatment options exist seeking to mitigate the negative consequences of the use of harmful substances.
Christopher, Fairgrieve +3 more
openaire +2 more sources
Systematic Reviews, 2021 Background Although oral opioid agonist therapies (OATs), buprenorphine and methadone, are effective first-line treatments, OAT remains largely underutilized due to low retention rates and wide variation across programs.
J. Klimas +5 more
semanticscholar +1 more source
Drug and Alcohol Dependence, 2022 BACKGROUND Injecting-related bacterial and fungal infections cause substantial illness and disability among people who use illicit drugs. Opioid agonist treatment (OAT) reduces injecting frequency and the transmission of blood borne viruses. We estimated
Samantha Colledge-Frisby +8 more
semanticscholar +1 more source
Opioid Receptors in Immune and Glial Cells-Implications for Pain Control [PDF]
, 2020 Opioid receptors comprise μ (MOP), δ (DOP), κ (KOP), and nociceptin/orphanin FQ (NOP) receptors. Opioids are agonists of MOP, DOP, and KOP receptors, whereas nociceptin/orphanin FQ (N/OFQ) is an agonist of NOP receptors.
Celik, Melih Ö., Machelska, Halina
core +1 more source
PLoS Medicine, 2022 Background Injecting-related bacterial and fungal infections are associated with significant morbidity and mortality among people who inject drugs (PWID), and they are increasing in incidence. Following hospitalization with an injecting-related infection,
T. Brothers +8 more
semanticscholar +1 more source